FDA grants accelerated approval for ADUHELM™ as the first and on
BIIB: Biogen Inc.
2021-06-07 13:00:00
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
2021-06-07 13:00:00
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease